Thai PBS Thai PBS
Research on mixed use of Sinovac and AstraZeneca vaccines to be conducted at Chulalongkorn University

Research on mixed use of Sinovac and AstraZeneca vaccines to be conducted at Chulalongkorn University

23 Sept 03:17 Key points summarised by AI
  • Chulalongkorn University's Centre of Excellence in Clinical Virology will launch research and human trials on the mixed use of Sinovac and AstraZeneca COVID-19 vaccines.
  • The study aims to provide solutions for vaccine side effects or shortages, with initial observations indicating enhanced immune responses in individuals who received mixed doses.
  • Led by Dr. Yong Poovorawan, the project seeks funding and ethical approval to recruit volunteers for trials, drawing parallels with established mixed vaccine use for other diseases and international studies on COVID-19 vaccine combinations.
Read full article
News 1/1
Skip > Skip >